Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Articles Tagged With: diabetes

  • Diabetes in Pediatric ED Patients

    Emergency medicine providers commonly will encounter children with type 1 and type 2 diabetes. Unfortunately, the incidence of both is increasing, and the acute care provider must be able to recognize the subtle and dramatic presentations of both diseases. Early recognition and management of both the disease and its complications — diabetic ketoacidosis, hyperglycemic hyperosmolar state, and cerebral edema — are critical to ensure an optimal outcome.

  • Dapagliflozin Treatment Improves Life Quality for Systolic Heart Failure Patients

    Treatment with dapagliflozin for 12 weeks resulted in improved health status, either a reduction in NT-proBNP or improvement in quality of life measures, in systolic heart failure patients with or without type 2 diabetes mellitus.

  • The Health Effects of Magnesium: Part 2

    Prospective outcomes studies are demonstrating that individuals are not meeting their daily magnesium intake needs and this may be contributing to a number of chronic health conditions including diabetes, hypertension, short sleep, and some pain conditions.

  • Dapagliflozin Treatment Improves Life Quality for Systolic Heart Failure Patients

    Treatment with dapagliflozin for 12 weeks resulted in improved health status, either a reduction in NT-proBNP or improvement in quality of life measures, in systolic heart failure patients with or without type 2 diabetes mellitus.

  • Semaglutide Tablets (Rybelsus)

    Semaglutide is indicated as adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

  • Lifestyle Modification for the Prevention and Reversal of Cardiovascular Disease

    Lifestyle is a critical determinant of the common risk factors for cardiovascular disease (hypertension, diabetes, hyperlipidemia, and smoking) that have been well-known to predict disease outcomes. Lifestyle medicine can be used in conjunction with traditional medications to provide the best care to patients. Clinicians need to act now to prevent being overwhelmed with the eventual increase in coronary artery disease following the obesity/diabetes epidemic.

  • Why Insulin? Addressing Social and Psychological Barriers

    Providers and patients can be confused by the increasing number of available insulin products.
  • Insulin Therapy for Type 2 Diabetes: Social, Psychological, and Clinical Factors

    The choices for insulin therapy are ever increasing with the development of new products that provide greater flexibility, greater range of effectiveness, lower risk of hypoglycemia, and lower pharmacokinetic and pharmacodynamic variability. These allow for individualization of treatment to match a patient’s daily life but typically at greater cost. This article will review the psychological, social, and clinical factors pertaining to the various insulin products, as well as strategies to initiate and intensify insulin therapy, to help clinicians supplement and enhance their clinical practices in diabetes management.

  • Keep Heart Health in Mind During Annual Exams

    With cardiovascular disease now the leading cause of death for women, the American Heart Association and the American College of Obstetricians and Gynecologists have issued a joint advisory to help women lower their risk factors for heart disease and stroke.

  • Vitamin D and Glycemic Control in Patients with Type 2 Diabetes

    Findings from a meta-analysis show vitamin D supplementation was associated with improved glycemic control in vitamin D-deficient or non-obese patients with type 2 diabetes.